Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Liontrust Asset Management seeking new chairman - report

(Sharecast News) - Liontrust Asset Management has reportedly embarked on a search for a new chairman months after it was forced to end its pursuit of rival GAM amid disquiet among shareholders. According to Sky News, Liontrust is working with headhunters to find a successor to Alastair Barbour, whose 13-year tenure on its board is expected to end in the coming months.

The search, which has been under way for some time, comes after a tumultuous year for the company, which has seen billions of pounds in outflows as well as a failed M&A strategy.

It walked away from the Swiss-based fund manager GAM last summer after the target's investors refused to back the deal, dealing a major blow to Barbour and chief executive John Ions.

Liontrust was ejected from London's FTSE 250 index after its shares halved in the last year.

In its annual report published last autumn, Liontrust said that Barbour would remain as chairman for a maximum of two more years. He has only chaired the company since September 2019, but is already "timed out" under UK corporate governance guidelines.

Last autumn, 15% of investors voted against his re-election, while earlier last year it was reported that two non-executive directors had resigned in protest at the length of his tenure on the board.

Sky said it was unclear on Thursday whether Liontrust was considering any of its existing board members as candidates to replace Barbour.

Share this article

Related Sharecast Articles

TSB appoints Marc Armengol as new CEO
(Sharecast News) - TSB said on Friday that it has appointed Marc Armengol as its new chief executive officer.
Genedrive full-year revenue rises
(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive reported a significant increase in revenue in its full-year results on Friday.
Former Bushveld subsidiary defaults on loan repayment
(Sharecast News) - Bushveld Minerals announced on Friday that Vanchem, a subsidiary it recently sold, has failed to repay ZAR 14.4m (£0.63m) plus accrued interest, which was due 21 November.
Atlantic Lithium progressing Ewoyaa despite mining lease delays
(Sharecast News) - Atlantic Lithium reported significant milestones in advancing the Ewoyaa Lithium Project in Ghana in an update on Friday, despite ongoing delays in the ratification of the project's mining lease.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.